home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Problems With A Potential Alzheimer Disease Treatment

  December, 6 2006 10:09
your information resource in human molecular genetics
An enzyme that produces a toxic protein involved in Alzheimer disease is also important for myelination or insulation of nerve cell axons, according to a study in the December 2006 issue of Nature Neuroscience. These results suggest that targeting this enzyme (BACE1) as a treatment for Alzheimer disease may produce significant adverse side effects.

Most nerve cell axons are wrapped with a layer of myelin, which acts like an insulator of electrical wires to allow nerve impulses to travel more quickly to their destination. Riqiang Yan and colleagues studied mice with a deletion of the BACE1 gene to determine the effects of eliminating this enzyme. The thickness of the myelin sheath in these mice was reduced along axons throughout the brain and spinal cord. These effects were visible as early as 15 days following birth and lasted into adulthood. The authors show that under normal conditions BACE1 exerts its effect by activating neuregulin, a known participant in the initiation of myelination.

Behavioral testing also revealed that these mice exhibited lower pain thresholds and decreased grip strength - typical signs of demyelination. Although inhibition of BACE1 may be a viable candidate for reducing the conversion of amyloid precursor protein into the plaques deposits seen in Alzheimer disease, these results suggest that as a therapeutic technique, it should be approached with caution.

Author contact:

Riqiang Yan (Cleveland Clinic, Cleveland, Ohio, USA)
E-mail: yanr@ccf.org

Abstract available online.

(C) Nature Neuroscience press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.